Suppliers / TIEN (Tianjin) Pharmaceutical

TIEN (Tianjin) Pharmaceutical

China Updated 9 July 2026

TIEN (Tianjin) Pharmaceutical is an API manufacturer based in China. It holds 5 active US drug master files across a filed portfolio of 4 molecules. Its most recent recorded inspection, by US FDA, closed on 7 July 2017 as NAI.

5
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 7 July 2017 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
China, China 3010666505

What they file, and where

Molecule Regulators Docs
Treprostinil US FDA 2
Alprostadil US FDA 1
Carboprost US FDA 1
Dinoprostone US FDA 1

Also appears on these molecule pages

Alprostadil API Carboprost API Treprostinil API

Questions about TIEN (Tianjin) Pharmaceutical

Does TIEN (Tianjin) Pharmaceutical hold a US DMF or a CEP?
TIEN (Tianjin) Pharmaceutical holds 5 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is TIEN (Tianjin) Pharmaceutical FDA-registered?
One site operated by TIEN (Tianjin) Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did TIEN (Tianjin) Pharmaceutical's last inspection go?
The most recent inspection on record closed on 7 July 2017 as NAI (No Action Indicated: nothing objectionable was found). 1 inspection is on file.
Where does TIEN (Tianjin) Pharmaceutical manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
What does TIEN (Tianjin) Pharmaceutical make?
4 molecules are on record against TIEN (Tianjin) Pharmaceutical, including Treprostinil, Alprostadil, Carboprost and Dinoprostone. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. TIEN (Tianjin) Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 7 July 2017.

Comparable suppliers

MSN Laboratories shares 2 molecules Everlight Chemical Industrial shares 2 molecules Chirogate International shares 2 molecules Dr Reddy's Laboratories shares 1 molecule Apotex shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability